Novartis AG vs Royal Bank of Canada
Vergelijking van marktkapitalisatie in de tijd
Novartis AG
$267.3B
Rang #55
Royal Bank of Canada
$300.5B
Rang #50
Marktkapitalisatie in de tijd
Belangrijke momenten
- Royal Bank of Canada streefde Novartis AG voorbij tegen 2025
Jaar-op-jaarvergelijking
| Jaar | Novartis AG | Royal Bank of Canada | Koploper |
|---|---|---|---|
| 2026 | $267.3B | $300.5B | Royal Bank of Canada |
| 2025 | $227.3B | $234.1B | Royal Bank of Canada |
| 2024 | $177.6B | $167.7B | Novartis AG |
| 2023 | $163.8B | $124.8B | Novartis AG |
| 2022 | $146.3B | $113.7B | Novartis AG |
| 2021 | $134.5B | $115.4B | Novartis AG |
| 2020 | $134.7B | $86.7B | Novartis AG |
| 2019 | $142.4B | $81.4B | Novartis AG |
| 2018 | $110.8B | $71.2B | Novartis AG |
| 2017 | $104.0B | $75.4B | Novartis AG |
| 2016 | $89.6B | $64.3B | Novartis AG |
| 2015 | $100.4B | $50.3B | Novartis AG |
| 2014 | $103.4B | $52.3B | Novartis AG |
| 2013 | $76.6B | $44.9B | Novartis AG |
| 2012 | $59.2B | $36.2B | Novartis AG |
| 2011 | $52.5B | $30.1B | Novartis AG |
| 2010 | $51.1B | $29.2B | Novartis AG |
| 2009 | $50.7B | $30.3B | Novartis AG |
| 2008 | $44.5B | $18.5B | Novartis AG |
| 2007 | $50.6B | $24.9B | Novartis AG |
| 2006 | $55.9B | $26.4B | Novartis AG |
| 2005 | $53.9B | $20.9B | Novartis AG |
| 2004 | $43.8B | $14.4B | Novartis AG |
| 2003 | $42.0B | $13.4B | Novartis AG |
| 2002 | $36.9B | $12.3B | Novartis AG |
| 2001 | $43.1B | $10.7B | Novartis AG |
| 2000 | $50.7B | $10.2B | Novartis AG |
| 1999 | $40.7B | $6.2B | Novartis AG |
| 1998 | $46.3B | $7.2B | Novartis AG |
| 1997 | $40.1B | $7.0B | Novartis AG |
| 1996 | $24.5B | $4.3B | Novartis AG |
| 1995 | $16.9B | $2.7B | Novartis AG |